This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Ondansetron |
| Description |
Ondansetron or GlaxoSmithKline's Zofran is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy. |
| Therapeutic Low |
0.0200 |
| Therapeutic High |
0.0650 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
3.00 |
| Half Life High |
32.00 |
| VOD Low |
0.00 |
| VOD High |
0.00 |
| Toxic Level |
0.000 |
| Lethal Level |
0.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
|